Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Franca Falzetti"'
Autor:
Roberta La Starza, Tiziana Pierini, Lorenza Pastorino, Elisa Albi, Caterina Matteucci, Barbara Crescenzi, Paolo Sportoletti, Piero Covarelli, Franca Falzetti, Giovanni Roti, Stefano Ascani, Cristina Mecucci
Publikováno v:
Molecular Cytogenetics, Vol 11, Iss 1, Pp 1-6 (2018)
Abstract Background Collision tumors are rare entities that consist of two histologically distinct tumor types arising in the same anatomic site. An association between chronic lymphocytic leukemia (CLL) and malignant melanoma (MM) has been already d
Externí odkaz:
https://doaj.org/article/570ee78259ae4b429f4a3deddba5327e
Autor:
Lidia Borghi, Sara Galimberti, Claudia Baratè, Massimiliano Bonifacio, Enrico Capochiani, Antonio Cuneo, Franca Falzetti, Alessandra Iurlo, Francesca Lunghi, Claudia Minotto, Ester Maria Orlandi, Giovanna Rege-Cambrin, Simona Sica, Sharon Supekar, Jens Haenig, Elena Vegni
Publikováno v:
Frontiers in Psychology, Vol 10 (2019)
Background: The main objective of this study is to gain further insights on how chronic myeloid leukemia (CML) patients involved in an interventional clinical trial with the purpose of reaching treatment free remission (TFR) phase, perceived and expe
Externí odkaz:
https://doaj.org/article/1e6f0d50c1e24084865d668154776977
Autor:
Mauro Di Ianni, Beatrice Del Papa, Stefano Baldoni, Ambra Di Tommaso, Bianca Fabi, Emanuela Rosati, Annalisa Natale, Stella Santarone, Paola Olioso, Gabriele Papalinetti, Raffaella Giancola, Patrizia Accorsi, Paolo Di Bartolomeo, Paolo Sportoletti, Franca Falzetti
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
In allogeneic hematopoietic stem cell transplantation, which is the major curative therapy for hematological malignancies, T cells play a key role in the development of graft-versus-host disease (GvHD). NOTCH pathway is a conserved signal transductio
Externí odkaz:
https://doaj.org/article/8f236388b87f4c4591b90c05041343c9
Autor:
Emanuela Rosati, Stefano Baldoni, Filomena De Falco, Beatrice Del Papa, Erica Dorillo, Chiara Rompietti, Elisa Albi, Franca Falzetti, Mauro Di Ianni, Paolo Sportoletti
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Chronic lymphocytic leukemia (CLL) is an incurable B-cell neoplasm characterized by highly variable clinical outcomes. In recent years, genomic and molecular studies revealed a remarkable heterogeneity in CLL, which mirrored the clinical diversity of
Externí odkaz:
https://doaj.org/article/36d9f649ddc84b009499ec08ae48b5ad
Autor:
Mauro Di Ianni, Stefano Baldoni, Beatrice Del Papa, Patrizia Aureli, Erica Dorillo, Filomena De Falco, Elisa Albi, Emanuela Varasano, Ambra Di Tommaso, Raffaella Giancola, Patrizia Accorsi, Gianluca Rotta, Chiara Rompietti, Estevão Carlos Silva Barcelos, Antonio Francesco Campese, Paolo Di Bartolomeo, Isabella Screpanti, Emanuela Rosati, Franca Falzetti, Paolo Sportoletti
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
To investigate chronic lymphocytic leukemia (CLL)-initiating cells, we assessed NOTCH1 mutation/expression in hematopoietic stem cells (HSCs). In NOTCH1-mutated CLL, we detected subclonal mutations in 57% CD34+/CD38− HSCs. NOTCH1 mutation was prese
Externí odkaz:
https://doaj.org/article/22cb5b5b90a04145889dadc04b8f6e35
Autor:
Sara Galimberti, Elena Ciabatti, Giacomo Ercolano, Susanna Grassi, Francesca Guerrini, Nadia Cecconi, Martina Rousseau, Giulia Cervetti, Francesco Mazziotta, Lorenzo Iovino, Franca Falzetti, Flavio Falcinelli, Alberto Bosi, Luigi Rigacci, Sofia Kovalchuk, Daniele Vallisa, Lucia Macchia, Eugenio Ciancia, Mario Petrini
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
R-Bendamustine is an effective treatment for follicular lymphoma (FL). Previous large trials demonstrated the prognostic role of the molecular minimal residual disease (MRD) during the most frequently adopted chemotherapeutic regimens, but there are
Externí odkaz:
https://doaj.org/article/35b73cce08bf4c5f99731c2b93b4f543
Autor:
Paolo Sportoletti, Emanuela Rosati, Mauro Di Ianni, Franca Falzetti, Maria Paola Martelli, Guido Montanaro, Andrea Marra, Ambra Di Tommaso, Roberta Iacucci Ostini, Elisa Albi, Estevão Carlos Silva Barcelos, Federica Mezzasoma, Francesco Maria Adamo, Manuel Nogarotto, Daniele Sorcini, Maria Grazia Cantelmi, Debora Cecchini, Chiara Rompietti, Filomena De Falco, Erica Dorillo, Stefano Baldoni, Beatrice Del Papa
Figure S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bec17ba17c9787a614b9bbd2801f41c
https://doi.org/10.1158/1078-0432.22471380
https://doi.org/10.1158/1078-0432.22471380
Autor:
Paolo Sportoletti, Emanuela Rosati, Mauro Di Ianni, Franca Falzetti, Maria Paola Martelli, Guido Montanaro, Andrea Marra, Ambra Di Tommaso, Roberta Iacucci Ostini, Elisa Albi, Estevão Carlos Silva Barcelos, Federica Mezzasoma, Francesco Maria Adamo, Manuel Nogarotto, Daniele Sorcini, Maria Grazia Cantelmi, Debora Cecchini, Chiara Rompietti, Filomena De Falco, Erica Dorillo, Stefano Baldoni, Beatrice Del Papa
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08213d6c0f6644f20568831b0e789e00
https://doi.org/10.1158/1078-0432.22471362.v1
https://doi.org/10.1158/1078-0432.22471362.v1
Autor:
Angelo Vacca, Franco Dammacco, Domenico Ribatti, Attilio Guarini, Nicola Di Renzo, Antonio Tabilio, Diego Guidolin, Giuseppe Mangialardi, Franca Falzetti, Teresa Cirulli, Claudia Piccoli, Roberto Ria
Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82cea0b7e1f8d7fc5e30cde70164adb3
https://doi.org/10.1158/1078-0432.22441036
https://doi.org/10.1158/1078-0432.22441036
Autor:
Paolo Sportoletti, Emanuela Rosati, Mauro Di Ianni, Franca Falzetti, Maria Paola Martelli, Guido Montanaro, Andrea Marra, Ambra Di Tommaso, Roberta Iacucci Ostini, Elisa Albi, Estevão Carlos Silva Barcelos, Federica Mezzasoma, Francesco Maria Adamo, Manuel Nogarotto, Daniele Sorcini, Maria Grazia Cantelmi, Debora Cecchini, Chiara Rompietti, Filomena De Falco, Erica Dorillo, Stefano Baldoni, Beatrice Del Papa
Purpose:Ibrutinib, a Bruton tyrosine kinase inhibitor (BTKi), has improved the outcomes of chronic lymphocytic leukemia (CLL), but primary resistance or relapse are issues of increasing significance. While the predominant mechanism of action of BTKi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ff165291a87757c7b419c2e16d63a2
https://doi.org/10.1158/1078-0432.c.6527862
https://doi.org/10.1158/1078-0432.c.6527862